Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Zhejiang Medicine Co Ltd

600216:SHH

Zhejiang Medicine Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)18.14
  • Today's Change1.65 / 10.01%
  • Shares traded89.27m
  • 1 Year change+66.57%
  • Beta0.7625
Data delayed at least 15 minutes, as of Nov 01 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zhejiang Medicine Co., Ltd. is a China-based company, principally engaged in the manufacture and distribution of drugs and nourishments. The Company mainly provides nourishments for animals and human, health care products, and chemicals and chemical raw materials, among others. The Company's products include synthetic vitamin E, natural vitamin E soft capsules, Beta carotene, vancomycin hydrochloride for injection and teicoplanin for injection, among others. The Company distributes its products within domestic market and to overseas markets.

  • Revenue in CNY (TTM)9.03bn
  • Net income in CNY977.95m
  • Incorporated1997
  • Employees6.23k
  • Location
    Zhejiang Medicine Co LtdNo. 168 Zhiyuanzhong AvenueBinhai XinchengSHAOXING 312366ChinaCHN
  • Phone+86 57 585211969
  • Fax+86 57 585211976
  • Websitehttps://www.zmc.top/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Chongqing Taiji Industry Group Co Ltd13.87bn609.10m14.31bn12.59k23.503.58--1.031.091.0924.917.180.96962.825.081,102,051.004.460.781412.442.3542.3144.034.600.84980.46655.500.552825.7610.587.88131.9963.553.8624.57
Sunshine Guojian Pharmcutcl Shngh Co Ltd1.22bn363.75m14.49bn965.0039.852.86--11.850.58970.58971.988.230.22141.546.631,267,186.006.361.326.971.4175.7380.7428.726.553.24--0.00988.2522.84-2.35497.63-4.4421.22--
Zhejiang Jiuzhou Pharmaceutical Co Ltd4.91bn697.36m14.70bn4.88k21.091.72--2.990.77490.77495.459.510.44051.754.201,007,191.006.2810.107.6713.6932.6134.6414.2516.262.48--0.090940.791.4424.2912.2045.7432.1420.11
Zhejiang Medicine Co., Ltd.9.03bn977.95m15.86bn6.23k16.121.53--1.761.021.029.5410.750.6942.946.011,450,206.006.574.328.365.6836.6336.579.466.281.7826.620.068458.72-3.962.59-20.373.3412.650.00
Shanghai Shyndec Pharmaceutical Co Ltd11.50bn1.08bn16.23bn11.61k14.991.24--1.410.80710.80718.589.750.5883.117.16990,814.206.994.8510.168.1737.7343.0011.887.032.03--0.101217.52-6.861.2910.21-0.3897-2.210.00
Suzhou Zelgen Biopharmaceuticals Co Ltd488.45m-174.40m16.36bn867.00--12.56--33.50-0.6692-0.66921.864.920.16770.26154.39563,380.80-6.54-27.13-11.06-39.2092.6492.75-39.00-220.711.83--0.4159--27.83211.8139.08--41.38--
Tonghua Dongbao Pharmaceutical Co Ltd2.43bn341.31m16.77bn3.20k54.662.61--6.890.15480.15481.253.240.33940.74263.70760,839.104.7618.685.0419.6877.3178.7314.0339.202.60--0.071241.7310.692.69-26.176.85-14.754.56
Data as of Nov 01 2024. Currency figures normalised to Zhejiang Medicine Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

3.16%Per cent of shares held by top holders
HolderShares% Held
Yinhua Fund Management Co., Ltd.as of 30 Jun 20245.57m0.58%
Shanghai Wealspring Asset Management Co. Ltd.as of 30 Jun 20234.77m0.50%
GF Fund Management Co., Ltd.as of 30 Jun 20244.00m0.42%
Bessemer Investment Management LLCas of 31 Jul 20242.87m0.30%
Bosera Asset Management Co., Ltd.as of 30 Jun 20242.87m0.30%
The Vanguard Group, Inc.as of 02 Oct 20242.27m0.24%
Galaxy Asset Management Co., Ltd.as of 30 Jun 20242.26m0.24%
SWS MU Fund Management Co., Ltd.as of 30 Jun 20242.19m0.23%
Ping An Fund Management Co., Ltd.as of 30 Jun 20241.77m0.19%
China Asset Management Co., Ltd.as of 30 Jun 20241.75m0.18%
More ▼
Data from 30 Jun 2024 - 23 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.